Genentech adds BioPlus to limited-distribution network for Tarceva

ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy has been added to the limited-distribution network for a Genentech drug used to treat lung and pancreatic cancers.

BioPlus announced that it had become a distributor for the drug Tarceva (erlotinib) starting Monday, when the drug, made by Genentech and Astellas, ceased to be available in retail pharmacies.

"BioPlus has worked for many years with patients taking Tarceva, and we look forward to continuing to service oncology patients as one of the small number of specialty pharmacies with ongoing access to this limited drug," BioPlus director of pharmaceutical contract management Sharon Ferrer said.